Big news from REMEDI!

Big news from REMEDI! REMEDI Inc. has officially passed the Korea Exchange (KRX) preliminary listing review for KOSDAQ — a major step toward becoming a publicly listed company on one of Asia’s leading technology exchanges.

For our partners, distributors, and every health team using REMEDI UPXR in the field: this milestone means greater stability, stronger investment in technology, and our deepest commitment yet to the communities we serve together. In the Philippines, REMEDI UPXR helped the Philippine Tuberculosis Society, Inc. (PTSI) screen over 122,000 individuals for TB in 2025 — a 400% increase in a single year. That number is why we do what we do. To everyone who has been part of this journey — thank you. The best is still ahead. 💙 #PortamedCorp #REMEDI #KOSDAQ #PortableXray #TBFreePhilippines #PTSI #KoreanHealthtech #MedicalImaging #ActiveCaseFinding